XML 24 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Stock options
Sep. 30, 2012
Stock options
Sep. 30, 2013
Stock options
Sep. 30, 2012
Stock options
Sep. 30, 2013
Stock options
Minimum
Sep. 30, 2013
Stock options
Maximum
Sep. 30, 2013
Restricted stock
Sep. 30, 2012
Restricted stock
Sep. 30, 2013
Restricted stock
Sep. 30, 2012
Restricted stock
May 31, 2010
Bruker Corporation Stock Plan
Sep. 30, 2013
Bruker Corporation Stock Plan
Minimum
Sep. 30, 2013
Bruker Corporation Stock Plan
Maximum
Sep. 30, 2013
Bruker Corporation Stock Plan
Stock options
Sep. 30, 2013
Bruker Corporation Stock Plan
Restricted stock
Oct. 31, 2009
Bruker Energy and Supercon Technologies Stock Plan
Sep. 30, 2013
Bruker Energy and Supercon Technologies Stock Plan
Minimum
Sep. 30, 2013
Bruker Energy and Supercon Technologies Stock Plan
Maximum
Sep. 30, 2013
Bruker Energy and Supercon Technologies Stock Plan
Stock options
Stock-Based Compensation                                              
Total stock-based compensation $ 1.6 $ 2.1 $ 4.8 $ 5.9 $ 1.3 $ 1.7 $ 3.9 $ 5.0     $ 0.3 $ 0.4 $ 0.9 $ 0.9                  
Vesting period                 3 years 5 years           3 years 5 years       3 years 5 years  
Risk-free interest rate, minimum (as a percent)             1.07% 0.91%                              
Risk-free interest rate, maximum (as a percent)             2.45% 1.78%                              
Expected life             6 years 6 months 6 years 6 months                              
Volatility (as a percent)             54.90% 55.90%                              
Expected dividend yield (as a percent)             0.00% 0.00%                              
Common stock authorized for issuance (in shares)                             8,000,000         1,600,000      
Stock option, Number of shares                                              
Outstanding at the beginning of the period (in shares)                                   4,888,137         800,000
Granted (in shares)                                   1,062,280          
Exercised (in shares)                                   (837,173)          
Forfeited (in shares)                                   (190,695)         (280,000)
Outstanding at the end of the period (in shares)                                   4,922,549         520,000
Exercisable at the end of the period (in shares)                                   2,755,035          
Exercisable and expected to vest at the end of the period (in shares)                                   4,770,823          
Stock options, Weighted Average exercise price                                              
Outstanding at the beginning of the period (in dollars per share)                                   $ 11.11          
Granted (in dollars per share)                                   $ 19.19          
Exercised (in dollars per share)                                   $ 9.56          
Forfeited (in dollars per share)                                   $ 11.30          
Outstanding at the end of the period (in dollars per share)                                   $ 13.11          
Exercisable at the end of the period (in dollars per share)                                   $ 10.55          
Exercisable and expected to vest at the end of the period (in dollars per share)                                   $ 13.01          
Stock options, Weighted average remaining contractual life                                              
Outstanding at the end of the period                                   6 years 6 months          
Exercisable at the end of the period                                   4 years 9 months 18 days          
Exercisable and expected to vest at the end of the period                                   6 years 4 months 24 days          
Stock options, Aggregate intrinsic value                                              
Outstanding at the end of the period (in dollars)                                   37.2          
Exercisable at the end of the period (in dollars)                                   27.8          
Exercisable and expected to vest at the end of the period (in dollars)                                   36.6          
Fair value of the Company's common stock price (in dollars per share)                                   $ 20.65          
Restricted stock, Number of shares                                              
Outstanding at the beginning of the period (in shares)                                     341,622        
Granted (in shares)                                     121,072        
Vested (in shares)                                     (93,646)        
Forfeited (in shares)                                     (11,100)        
Outstanding at the end of the period (in shares)                                     357,948        
Restricted stock, Weighted-average grant date fair value                                              
Non-vested at the beginning of the period (in dollars per share)                                     $ 15.16        
Granted (in dollars per share)                                     $ 19.10        
Vested (in dollars per share)                                     $ 15.13        
Forfeited (in dollars per share)                                     $ 10.25        
Non-vested at the end of the period (in dollars per share)                                     $ 16.65        
Expected pre-tax stock-based compensation expense                                   $ 17.6 $ 5.4       $ 0.3
Weighted average remaining service period                                   3 years 3 years 4 months 24 days       1 year